expert Q&A
expert Q&A
04/13/2024

James W. Antoon, MD, PhD, MPH

James W. Antoon, MD, PhD, MPH
In this expert Q and A, James W. Antoon, MD, PhD, MPH, discusses the results of his team's recent study examining the rate of neuropsychiatric events associated with influenza infection and treatment in...
04/13/2024
Expert Q&A
W. Clay Jackson, MD, DipTH
Expert Q&A
02/05/2024
In this Q&A, W. Clay Jackson, MD, DipTH, speaks about various aspects of schizophrenia, including the symptoms, risk factors, and associated controversies surrounding these risk factors.
02/05/2024
Expert Q&A
Clay Jackson, MD, DipTh
Expert Q&A
05/29/2023
In this Q&A, W. Clay Jackson, MD, answers questions about the positive and negative symptoms, the therapeutic challenges, the gold standard of treatment of patients with schizophrenia, and some...
05/29/2023
Anxiety Disorders
Anxiety Disorders
02/10/2023
In this Q&A, Sat Bir S. Khalsa, PhD, answered our questions about his team’s study that evaluated the efficacy of yoga vs cognitive behavioral therapy vs stress education for the treatment of generalized...
02/10/2023
Autism
Autism
07/25/2022
Alexandra Kirsch, PhD, discussed her study which found that individuals with autism spectrum disorder (ASD) may have an increased risk of comorbid depression, bipolar disorder, and anxiety compared with...
07/25/2022
mental health
mental health
06/10/2022
A recent study compared the use of mental health and physical health services among mothers of children with multiple sclerosis (MS) and those of children without MS. Lead researcher Ruth Ann Marrie, MD,...
06/10/2022
Mental Health
Mental Health
03/23/2022
In this Q&A, lead author Shahina Pardhan, PhD, discusses her study that found dual sensory impairment is associated with increased depression and anxiety, with women showing stronger associations than...
03/23/2022
mental health
mental health
03/17/2022
What is the association between depression and subsequent risk of rheumatoid arthritis by serologic phenotype? In this Q&A, Jeffrey Sparks, MD, explains.
03/17/2022
Expert Q&A
Expert Q&A
03/16/2022
Dr Jennifer Dwyer discusses the results from her randomized, double-blind, placebo-controlled crossover trial study that found a reduction in depression scores at 24 hours post treatments with ketamine...
03/16/2022
psychiatry
psychiatry
08/05/2021
Stanislav Spivak, MD, Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University and Medical Director of the Johns Hopkins Psychiatric Mobile Treatment program discusses the...
08/05/2021